Sahm Nasseri

Sahm Nasseri holds an extensive background in commercial drug development from his roles over the past 7 years while in the USA with Merck & Co, one of the world’s leading global biopharma companies. In that time, Sahm has built experience leading product teams and commercial strategy across a range of therapeutic areas, modalities and geographies as well as within Merck’s investor relations and business development functions. Prior to Merck, Sahm was a consultant with McKinsey & Company in Sydney. He holds a Bachelor of Chemical Engineering with Honours from the University of New South Wales and an MBA from Columbia Business School in New York City.